Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
Authors
Keywords
-
Journal
Frontiers in Bioengineering and Biotechnology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-10
DOI
10.3389/fbioe.2020.00512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
- (2019) Ghanbar Mahmoodi Chalbatani et al. International Journal of Nanomedicine
- Hepatocellular Carcinoma
- (2019) Augusto Villanueva NEW ENGLAND JOURNAL OF MEDICINE
- At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids
- (2019) Hasan Uludag et al. Frontiers in Bioengineering and Biotechnology
- Biodistribution and biocompatibility of glycyrrhetinic acid and galactose-modified chitosan nanoparticles as a novel targeting vehicle for hepatocellular carcinoma
- (2019) Min Li et al. Nanomedicine
- Molecular therapy using siRNA: Recent trends and advances of multi target inhibition of cancer growth
- (2018) Shweta Jain et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- siRNA delivery system based on magnetic nanovectors: Characterization and stability evaluation
- (2017) Mohammed Abdelrahman et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- MiR-221 mediates the epithelial-mesenchymal transition of hepatocellular carcinoma by targeting AdipoR1
- (2017) Tong Li et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review
- (2016) Giulia Suarato et al. Biointerphases
- Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
- (2016) Min Li et al. International Journal of Nanomedicine
- Role of pH-responsiveness in the design of chitosan-based cancer nanotherapeutics: A review
- (2016) Giulia Suarato et al. Biointerphases
- Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery
- (2015) Yang Yang et al. BIOMATERIALS
- Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin
- (2015) Omar Mezghrani et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
- (2015) Andrew X. Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo
- (2015) Cheol Jang et al. Nanoscale
- Galactosylated polymeric carriers for liver targeting of sorafenib
- (2014) Emanuela F. Craparo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG
- (2014) Ling Mei et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted Theranostic Platinum(IV) Prodrug with a Built-In Aggregation-Induced Emission Light-Up Apoptosis Sensor for Noninvasive Early Evaluation of Its Therapeutic Responses in Situ
- (2014) Youyong Yuan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer
- (2014) Chirine El-Baba et al. Molecular Cancer
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Fabrication of Chitosan Nanoparticles with Aggregation-Induced Emission Characteristics and Their Applications in Long-Term Live Cell Imaging
- (2013) Min Li et al. MACROMOLECULAR RAPID COMMUNICATIONS
- Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy
- (2012) Kazuhiro Takara et al. JOURNAL OF CONTROLLED RELEASE
- Impact of Silica Nanoparticle Design on Cellular Toxicity and Hemolytic Activity
- (2011) Tian Yu et al. ACS Nano
- Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery
- (2011) Golam Kibria et al. JOURNAL OF CONTROLLED RELEASE
- Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA
- (2011) Ditte Krohn Jensen et al. JOURNAL OF CONTROLLED RELEASE
- Glycyrrhetinic acid-functionalized degradable micelles as liver-targeted drug carrier
- (2011) Wei Huang et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Design and synthesis of dual-ligand modified chitosan as a liver targeting vector
- (2011) Houxiang Chen et al. JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
- Modification of chitosan nanoparticles for improved gene delivery
- (2011) Rekha M Ramesan et al. Nanomedicine
- Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery
- (2010) Qin Tian et al. BIOMATERIALS
- Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery
- (2010) Zhi Yao He et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Lysophosphatidic Acid Induces MDA-MB-231 Breast Cancer Cells Migration through Activation of PI3K/PAK1/ERK Signaling
- (2010) Jun Du et al. PLoS One
- Pak protein kinases and their role in cancer
- (2009) Bettina Dummler et al. CANCER AND METASTASIS REVIEWS
- Effect of Surface Properties on NanoparticleâCell Interactions
- (2009) Ayush Verma et al. Small
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now